VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -0.5% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 173 | -1 | 210.42M | $104.38B | +5 | −7 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | n/a | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | n/a |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | n/a | n/a |
| Q2 2024 | 19 | n/a | 46.47M | $21.77B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 26.81M | +0.4% | $12.47B | 1.9% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 5.94M | -6.2% | $2.75B | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 4.80M | +17.2% | $2.23B | 0.4% | ▲ Add | 2 | SEC ↗ ×8 |
| 4 | Norges Bank ✦ (passief) | 3.41M | -0.6% | $1.59B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.77M | -20.1% | $822.27M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Renaissance Technologies ✦ | 1.63M | +4.2% | $758.77M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 480.86K | -10.3% | $223.12M | 0.3% | ▼ Trim | 2 | SEC ↗ ×3 |
| 8 | Adage Capital Partners ✦ | 346.36K | +3.3% | $161.08M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 9 | Marshall Wace ✦ | 244.00K | +92.1% | $113.48M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 160.53K | -51.6% | $74.66M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 159.29K | +11.6% | $74.08M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 140.58K | -16.1% | $65.38M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 13 | D. E. Shaw & Co. ✦ | 138.41K | -18.6% | $64.37M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 14 | Tweedy, Browne ✦ | 53.60K | -1.4% | $24.93M | 1.2% | ▼ Trim | 2 | SEC ↗ |
| 15 | ARK Investment Management ✦ | 51.10K | -32.3% | $23.76M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 50.23K | -52.0% | $23.36M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 27.13K | +9.8% | $12.62M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 27.02K | -3.9% | $12.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 3.45K | -89.6% | $1.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,678 houders, 225.07M aandelen, $98.10B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.